haemoglobin.
The World Health Organization Study Group has recently suggested the evaluation of glycated haemoglobin [1] as an alternative method to plasma glucose measurement for screening of diabetes mellitus. At the present time, glycated haemoglobin measurement is considered as the best index of metabolic control in diabetic patients [2] [3] [4] [5] , providing a cumulative estimate of the mean blood glucose concentration over the preceding 2-3 months. However, its place in diabetes screening and diabetes diagnosis remains debatable. Different conclusions have been reached even between authors who have measured the major glycated haemoglobin, Ale (HbAlc) [6] [7] [8] [9] [10] , the most reliable indicator of long-term blood glucose [11] [12] [13] . Consensus has been obtained on a single point: the need for conducting longitudinal surveys in order to validate glycated haemoglobin measurement as a tool for diabetes screening [6, 9, I0,14,15] , by reproducing the epidemiological surveys which led to define the currently used plasma glucose criteria of diabetes [16] [17] [18] . As serotheques cannot be used for glycated haemoglobin measurement, prospective studies on the relation of glycated haemoglobin to the development of specific complications of diabetes are needed.~ They will require lengthy follow-up.
An initial approach consists in determining the factors associated with the distribution of glycated haemoglobin in a healthy population. Plasma glucose is known to vary with age [19, 20] , gender [20, 21] and season [22, 23] . In contrast, little epidemiological data are available concerning glycated haemoglobin. According to the most extensive reviews, glycated haemoglobin is considered to be influenced only by the erythrocyte life span and in diabetic patients by the blood glucose concentration [1l, 12, 24, 25] . The study presented here has been designed to address the specific issue of the possibility of using HbAto as a screening tool for diabetes mellitus. This paper reports the distribution of HbAte in a large, healthy adult population and the effects of age, sex, season, tobacco and the classic risk factors for diabetes. 
Subjects and methods
From April 1985 to July 1987, 3240consecutive subjects who voluntarily attended a centre for preventive medicine, were examined in a cross-sectional study; patients with haemoglobinopathies (1.5% of the total population), known diabetic patients and pregnant women were excluded. The subjects were "France Telecom" employees working in the Paris area. The study population consisted of adults, 40.2-+11.8 years old (mean_+ SD), age range: 18 to 81 years, with 51.8% women. "France Telecom" is a national public company employing 38000subjects in the Paris area (47.4% women), who retire between 60 and 65 years, depending on their occupation. Most of them are office workers and have little physical activity. They are invited to undergo a check-up, free of charge, every 5 years for those under 40 years of age and every 2 years for those over 40 years of age. A self-questionnaire, filled out at home and reviewed by a secretary during the consultation, inquired about tobacco consumption, gynaecological and obstetrical history, present oral contraceptive (OC) use and family history of diabetes in the first degree relatives. A physical examination recorded height, weight, blood pressure and subscapular skinfold thickness. The Quetelet index [weight(kg)/height(m) 2] was used as a measure of body mass index (BMI). Biological investigations included a 0-2 h oral glucose tolerance test (OGTT) with a 75 g glucose load given after an overnight fast and HbAlc measurement by a chromatographic technique derived from the Trivelli method [26] . In the same laboratory, a study of 32 diabetic patients, with samples measured in triplicate by this method, showed for HbAlc a residual standard error of 0.22% with a range from 0.06 to 0.40% and an intra-assay coefficient of variation equal to 2.8%. Table 1 describes the population of the study and compares each parameter between men and women. The data indicate that the studied population was in particularly good health. Concerning diabetes, its prevalence was low: 0.7% were newly discovered diabetic patients, defined by a 2 h-plasma glucose (2 h-PG) value >__ 11.1 mmol/l.
Statistical analysis
Statistical analysis was performed by the ~2 test for proportions, analysis of variance and correlation coefficients for quantitative variables and a stepwise multiple regression analysis by BMDP [27] .
Results

Distribution of HbAlc; role of sex and age
The distribution of HbAlc in the whole population was approximately normal (Fig.l) . Some characteristics of the sex-and age-specific distributions of HbAlc in the 3240 non-diabetic adults are shown in Table 2 . There was no difference in HbAlc according to gender: 5.03+0.53% in men vs 5.07+0.55% in women. Median values were the same in both sexes: 5.0%. A very slight difference existed between mean and median values: the greatest difference observed over all the age and sex groups was equal to 0.07%; this confirms the symmetry of the HbAlc distribution. The dispersion of HbAlc values, as reflected by the standard deviations, was remarkably constant over all the age groups.
As shown in Figure 2 , HbAtc increased linearly with age in both sexes (p < 0.001 for each sex). The percentile values were approximately similar in men and women (Table2). However, surprisingly enough, HbAto decreased in men over 60. This age class showed the only sex difference for average HbAlc: 5.05 + 0.57% for men vs 5.32_+ 0.63% for women (p <0.05). 
Role of menopause and oral contraceptives
Among women, HbAIo was higher in the post-menopausal, compared to the pre-menopausal group (Table 3) even after adjustment for BMI (p <0.001); in this group, no significant difference was observed according to the use of oestrogen therapy. In women of child-bearing age, HbAlc was lower in OC users (Table 3 ) (p < 0.001) but the difference was no longer significant after adjustment for age. In the whole population, HbAlc was higher where there was a family history of diabetes: 5.15 + 0.57% vs 5:03 ___ 0.53% (p < 0.001).
Influence of the other classic risk factors for diabetes
Obesity, defined by a BMI over 28 kg/m 2 [28] , was associated with a significantly higher level of HbAtc in 5, 3 . justment for age. On the contrary, the increase in HbAlo with age remained significant after adjustment for BMI in men (p < 0.01) as in women (p < 0.001). (Fig.3) . In both sexes, smokers were younger and leaner than non smokers. Nevertheless, male smokers had significantly higher values of HbAlc than male non smokers: 5.11+0.51% vs 4.99+0.54% (p<0.001). Female smokers had a slightly higher HbAlc level than female non smokers (5.09 + 0.54% vs 5.06 + 0.56%) and the difference was significant after adjustment for age (p<0.001).
Influence of season and tobacco consumption
Correlation coefficients of HbAlc with the other variables likely to influence its level are shown in Table 4 . In order to isolate the most powerful factors associated with the HbAtc level, a stepwise multiple regression analysis was performed including age, family history of diabetes, history of a large newborn delivery (for women), BMI, FPG, 2 h-PG, fasting plasma insulin, mean corpuscular volume, plasma cholesterol and or 7GT. When all these parameters were included in the model, the HbAI~ level was poorly explained: r 2 was equal to 0.03 in men and to 0.07 in women. However, in men and in women, age and then FPG were the only two factors which were significant.
Discussion
These cross-sectional data demonstrate that HbA~c concentrations are unimodally distributed in this healthy population. Such a unimodal distribution probably exists in all populations, except in populations having an extraordinarily high prevalence of diabetes such as the Pima Indians [14. ]. The present study suggests that HbAlc is influenced by very few factors. While FPG was higher and 2 h-PG was lower in men than women, as previously described [20, 21] , no significant sex difference exists for HbAlo, except for the group over sixty years of age, in which men had lower levels than women. A selection bias is the most probable explanation, with a healthy worker effect in this group of older men who were still working and volunteered for this medical examination. This hypothesis is supported by testosterone measurements: in this male adult population, the general trend of plasma testosterone was to decrease with age, as is usual [29] , but in the over-sixty group it increased [30] . Moreover, the sample size for men is approximately half of that for women in this age group, suggesting selection biases and a survivor effect. The lack of sex difference for HbAI~ in a healthy population, also demonstrated for HbAt [31, 32] , obviates the need for sex-specific reference standards. The increase of HbAt~ with ageing had been previously demonstrated in non-diabetic subjects between the ages of 50 and 89 years [33] . A controversial paper showing a lack of influence of ageing probably failed to show the role of age because of a lack of power due to small sample sizes [34] . The increase of glycated haeamoglobin with abnormality of glucose tolerance had been demonstrated in several studies although the distributions of glycated haemoglobin values for the three glucose tolerance classes overlapped [6] [7] [8] 10] . The relation of HbAlc with all the known risk factors for diabetes (age, obesity, family history of diabetes, history of large newborn delivery) must be underlined. In particular, the higher HbAI~ level in mothers having delivered large newborns, contrasts with the non significant differences observed in FPG and 2 h-PG values. The negligible influences of oestrogen replacement therapy in postmenopausal women and of OC use in women of childbearing age upon HbAlo level are parallel to the small hormonally induced modifications of FPG and 2 h-PG which have been observed in this population [35] as in other healthy populations [36, 37] . The lack of consistent seasonal variation of HbAlc in this study contrasts with data previously reported. In agreement with the known seasonal variations of FPG [22] and 2 h-PG [23] , the highest values of glycated haemoglobin had been observed at the ends of autumn and winter and the lowest at the ends of spring and summer [38] . In our study, not only HbAlc (Fig. 3) , but also FPG and fasting plasma insulin were significantly increased in winter 1986 compared to winter 1985 (respectively 5.1+0.5 vs 4.9_+ 0.7 mmol/l, p < 0.001 and 7.5 + 3.2 vs 7.0_+ 3.3 gu/ml, p < 0.01). Unusually mild weather in winter 1985 could have prevented the known increase of glycated haemoglobin [38] , FPG [22, 39] and plasma insulin [40] with the cold. The data from 1986 are probably more representative of the usual seasonal pattern of HbAlc and are in good agreement with the reported seasonal pattern of FPG, 2 h-PG and glycated haemoglobin [22, 23, 38] . This study shows an increase in HbAlc in smokers, as recently reported for HbA1 [32] ; this shift was more evident in men, heavier smokers than women (14.5 g vs 11.2 g of daily tobacco consumption). However, the correlation coefficient between HbAlc and tobacco consumption was not significant (r = 0.08 in either sex). So, the difference in consumption cannot explain the more important effect of tobacco upon HbAlo in men. Nevertheless, the increase in HbAlc in smokers contrasts with a lower level of FPG and 2 h-PG. By our method of HbAlc measurement, the quantity is not affected by the presence of carboxyhaemoglobin; therefore the higher HbA~c level in smokers cannot be due to an artefact. Considering that reactivity of the glucose molecules with the N-terminus of the [3-chain has been demonstrated to increase in the presence of carbon monoxide in vitro [41, 42] , it can be proposed as an hypothesis that this biochemical mechanism exists also in vivo and could explain the increased HbAIo in smokers. So, if we admit that glycosylation of Hb could be a marker of the development of diabetic complications [43] , these data provide an additional argument to recommend that diabetic patients not smoke.
All of the relationships between HbAlc and the factors measured appear weak, even when the link is found to be statistically significant due to the power of analysis provided by the large size of the studied population. In particular, with regard to the known influence of haematologic disorders upon glycated haemoglobin level [11, 25] , the low correlation coefficients observed here between HbA~c and mean corpuscular volume, as well as with erythrocyte count, indicate the negligible role of haematologic factors when HbAI~ is measured by a reliable technique in a healthy population. It must be remembered that an haemoglobinopathy was discovered in 1.5% of subjects, preventing accurate measurement of HbAI~. This percentage would have been close to zero if we had selected Caucasians as most of the excluded people were native from the West In-D. Simon et al.: Epidemiology of glycated haemoglobin Alc dies. Between HbAlc and plasma glucose values, the correlation coefficients appear strikingly low. Similar results, including an even weaker relationship with 2 h-PG than with FPG, have been previously observed in other healthy populations, for HbAI [32] as for HbAto [10] . The studied population had a low prevalence of diabetes (0.7%); a previous study in a diabetes screening centre in a high risk population with a high prevalence of diabetes (7.5%) found a correlation coefficient between HbAac and FPG equal to 0.52 and between HbAlc and 2 h-PG equal to 0.51 [9] , approaching the values observed in diabetic populations [44] . The discrepancy observed in the association between plasma glucose values and the HbAlc level indicates that, as soon as plasma glucose becomes abnormal -as in diabetic populations -HbAlo is more closely correlated with plasma glucose but, in a healthy population, HbAto appears as a very independent parameter, influenced only by factors closely linked to diabetes. Even if use of HbAlc measurement in population studies has obvious advantages such as the ability to use non-fasting specimens, and no need for a glucose challenge, further prospective studies are needed in order to determine whether HbAlc could be preferable to OGTT for diabetes screening because of prognostic as well as logistic considerations [10, 45] .
